Olivier Coux is a research director at the CNRS, CRBM-CNRS, Montpellier, France. He obtained his PhD degree at Paris 7 university in 1992. He obtained his habilitation to direct research (HDR) from the University of Montpellier in 1999. He was a postdoctoral fellow at Harvard Medical School, Boston, USA (1998-2020) and group leader of "Ubiquitin–proteasome system and cell cycle control" at the CRBM-CNRS, France. His research interests are focused on the study of proteasome regulators and ubiquitin-like proteins. He is a member of the French Society for Biochemistry and Molecular Biology (SFBBM), the American Society for Biochemistry and Molecular Biology (ASBMB) and the French Society of Cell Biology (SBCF). He is the coordinator of the COST ProteoCURE action (2021–2025).
Olivier Coux is a research director at the CNRS, CRBM-CNRS, Montpellier, France. He obtained his PhD degree at Paris 7 university in 1992. He obtained his habilitation to direct research (HDR) from the University of Montpellier in 1999. He was a postdoctoral fellow at Harvard Medical School, Boston, USA (1998-2020) and group leader of "Ubiquitin–proteasome system and cell cycle control" at the CRBM-CNRS, France. His research interests are focused on the study of proteasome regulators and ubiquitin-like proteins. He is a member of the French Society for Biochemistry and Molecular Biology (SFBBM), the American Society for Biochemistry and Molecular Biology (ASBMB) and the French Society of Cell Biology (SBCF). He is the coordinator of the COST ProteoCURE action (2021–2025).